VC Firm DFJ Has "One And Done" Close On $325 Million Fund XI

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Venture capital firm Draper Fisher Jurvetson said it has closed its early-stage focused Fund XI on $325 million after roughly two months in the market. The firm got a mix of existing and new investors into the fund, including new relationships with college endowments and a few chief executive officers and founders "in some of the biggest tech companies," according to managing director Josh Stein. Stein declined to name the CEOs and founders.

Help employers find you! Check out all the jobs and post your resume.

Back to news